TY  - JOUR 
AU  - Quintero, J.
AU  - López-Muñoz, F.
AU  - Álamo González, C
AU  - Loro, M.
AU  - García-Campos, N.
PY  - 2010
SN  - 1866-6116
SN  - 1866-6647
UR  - http://hdl.handle.net/20.500.12020/723
AB  - Up to 30% of patients with attention-deficit hyperactivity disorder (ADHD) treated with psychostimulants discontinue the treatment because of intolerance or lack of therapeutic response. Therapeutic alternatives are needed for such patients. In the...
LA  - en
PB  - Manfred Gerlach
TI  - Reboxetine for ADHD in children non-responders or with poor tolerance to methylphenidate: a prospective long-term open-label study
DO  - 10.1007/s12402-010-0027-x
T2  - ADHD Attention Deficit and Hyperactivity Disorders
M2  - 107
KW  - Roboxetina
KW  - ADHD
KW  - Hiperactividad
VL  - 2
ER  -